Lake Street Capital Initiates Coverage on Femasys (NASDAQ:FEMY)

Equities research analysts at Lake Street Capital initiated coverage on shares of Femasys (NASDAQ:FEMY) in a report released on Tuesday,Benzinga reports. The brokerage set a “buy” rating and a $1.50 price target on the stock. Lake Street Capital’s price target would suggest a potential upside of 174.98% from the company’s previous close.

Several other research firms have also commented on FEMY. Laidlaw assumed coverage on shares of Femasys in a research note on Thursday, November 20th. They set a “buy” rating and a $6.50 price objective for the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Femasys in a research report on Thursday, January 22nd. Finally, Wall Street Zen lowered Femasys from a “hold” rating to a “sell” rating in a report on Saturday, December 20th. Four analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $5.50.

Femasys Price Performance

FEMY opened at $0.55 on Tuesday. The firm has a market capitalization of $31.90 million, a PE ratio of -0.76 and a beta of -2.53. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.16 and a quick ratio of 0.61. The business’s 50-day moving average is $0.58 and its two-hundred day moving average is $0.62. Femasys has a 1 year low of $0.31 and a 1 year high of $1.76.

Hedge Funds Weigh In On Femasys

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Kovack Advisors Inc. purchased a new stake in Femasys during the 4th quarter valued at about $27,000. HRT Financial LP acquired a new stake in shares of Femasys during the fourth quarter worth about $30,000. Cetera Investment Advisers acquired a new stake in shares of Femasys during the fourth quarter worth about $36,000. Osaic Holdings Inc. purchased a new stake in Femasys in the second quarter valued at approximately $45,000. Finally, State Street Corp increased its holdings in Femasys by 43.5% in the 4th quarter. State Street Corp now owns 80,869 shares of the company’s stock worth $47,000 after buying an additional 24,500 shares during the period. Hedge funds and other institutional investors own 65.27% of the company’s stock.

About Femasys

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.